Industry Updates

Medtech POV Blog

AdvaMed®’s Medtech POV blog features all the latest developments, perspectives, and resources by and for the medical technology community.

Industry Updates

Subscribe to the RSS Feed

Diabetes / Diagnostics / Digital Health / Government & Legislative Affairs / Medical Imaging / Orthopedic / Radiation Therapy

Medtech Goes to Capitol Hill

AdvaMed’s annual Medtech Showcase and Reception on Capitol Hill seeks to inform a core audience: the members of the Congress and their staff who enact the policies that help our…

Global & Trade / Government & Legislative Affairs / Regulatory Affairs / Tariffs

Medtech is Essential: Industry Supports Call for Tariff Flexibility

AdvaMed® President and CEO Scott Whitaker testified before the U.S. Senate Finance Committee, bringing attention to the pressing issue of how tariffs could impact the medtech industry and, most importantly,…

Government & Legislative Affairs / Regulatory Affairs

Orthogonal, Kwame Ulmer on the Value ofAdvaMed® Membership

AtAdvaMed®, we’re proud to be recognized for our work on behalf of the medtech community – and we’re especially grateful when that recognition comes from respected voices like Kwame Ulmer…

The MedTech Conference

THE Medtech Event of the Year

Join thousands of industry leaders October 5-8, 2025, in San Diego, California for direct access to hundreds of hours of timely medtech education, networking with industry leaders and CEOs, and…

Listen to AdvaMed®'s Podcast

Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.

Value-Based Collaborations

Centering the Patient Voice in Medtech Innovation

AdvaMed® President and CEO Scott Whitaker describes the importance of engaging patients in every stage of medtech innovation.

Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs

Why Lifesaving Medtech Should Be Tariff-free: An Interview with AdvaMed’s CEO

AdvaMed® President and CEO Scott Whitaker is leading the call for a reciprocal “zero-for-zero” tariff agreement on medtech, urging the U.S. and its trading partners to eliminate tariffs on essential,…

Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs

Why the Administration Should Be Flexible with Medtech Tariffs to Protect Patients and Innovation

Flexibility on tariffs is critical to maintaining medtech as the backbone of the U.S. health care system and an American economic success story.

Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Regulatory Affairs / Small Business

AdvaMed®’s Medical Innovation Agenda for the 119th Congress

AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.